Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
Growth was broad-based across segments
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector
The system is powered by BrainSense technology, which has received approval from USFDA
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients
Move comes amid rising regulatory pressures
Subscribe To Our Newsletter & Stay Updated
